Seeing Is Believing
Currently out of the existing stock ratings of Konstantinos Aprilakis, 12 are a BUY (75%), 3 are a HOLD (18.75%), 1 are a SELL (6.25%).
Analyst Konstantinos Aprilakis works with a stock forecast success ratio of 65% fulfilled within 302.6 days on average. Previously, Konstantinos Aprilakis worked at STIFEL, DEUTSCHE BANK.
Konstantinos Aprilakis’s has documented 32 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on DCPH, Deciphera Pharmaceuticals LLC at 03-Dec-2020.
Analyst best performing recommendations are on STRO (SUTRO BIOPHARMA).
The best stock recommendation documented was for STRO (SUTRO BIOPHARMA) at 12/3/2020. The price target of $25 was fulfilled within 36 days with a profit of $8 (47.06%) receiving and performance score of 13.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
97
$4.74 (5.14%)
74
1 months 30 days ago
11/11 (100%)
$1.95 (2.05%)
89
Sell
65
$-27.26 (-29.55%)
46
2 months 9 days ago
10/11 (90.91%)
$-25.26 (-27.99%)
249
Buy
114
$21.74 (23.56%)
114
2 months 9 days ago
2/11 (18.18%)
$23.74 (26.30%)
273
Hold
70
$-22.26 (-24.13%)
58
2 months 12 days ago
8/9 (88.89%)
$-3.17 (-4.33%)
66
Buy
97
$4.74 (5.14%)
90
3 months 16 days ago
7/12 (58.33%)
$14.02 (16.90%)
229
What Year was the first public recommendation made by Konstantinos Aprilakis?